Patents by Inventor Lars Örning
Lars Örning has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11814669Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: GrantFiled: June 30, 2021Date of Patent: November 14, 2023Assignee: ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANYInventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
-
Publication number: 20210332410Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: ApplicationFiled: June 30, 2021Publication date: October 28, 2021Inventors: Arne Ludvig FAAREN, Frank FRANTZEN, Arne Kristian NORDHEI, Erling SUNDREHAGEN, Lars ØRNING
-
Patent number: 11085066Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: GrantFiled: October 31, 2019Date of Patent: August 10, 2021Assignee: AXIS-SHIELD ASInventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
-
Publication number: 20200278361Abstract: An assay cartridge has a base member (26) that defines at least two wells (30, 32, 34, 36, 38), a pipette (108, 110) positionable in at least one of the wells and a cap member (86) arranged to carry the pipette. The cap member can be releasably fastened to the base member. An extension member (28) defines at least one further well (40, 42, 44) and can be fastened to the base member such that the pipette is then positionable in at least one of the wells of the base and in the further well of the extension member.Type: ApplicationFiled: October 28, 2019Publication date: September 3, 2020Inventors: Lars Ørning, Frank Frantzen, Andrew Thomas Campbell, Arve Strømsheim
-
Publication number: 20200131560Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: ApplicationFiled: October 31, 2019Publication date: April 30, 2020Inventors: Arne Ludvig FAAREN, Frank FRANTZEN, Arne Kristian NORDHEI, Erling SUNDREHAGEN, Lars ØRNING
-
Patent number: 10494660Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: GrantFiled: June 21, 2017Date of Patent: December 3, 2019Assignee: AXIS-SHIELD ASInventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
-
Patent number: 10488425Abstract: An assay cartridge has a base member (26) that defines at least two wells (30, 32, 34, 36, 38), a pipette (108, 110) positionable in at least one of the wells and a cap member (86) arranged to carry the pipette. The cap member can be releasably fastened to the base member. An extension member (28) defines at least one further well (40, 42, 44) and can be fastened to the base member such that the pipette is then positionable in at least one of the wells of the base and in the further well of the extension member.Type: GrantFiled: November 19, 2017Date of Patent: November 26, 2019Assignee: AXIS-SHIELD ASInventors: Lars Ørning, Frank Frantzen, Andrew Thomas Campbell, Arve Strømsheim
-
Publication number: 20180156830Abstract: An assay cartridge has a base member (26) that defines at least two wells (30, 32, 34, 36, 38), a pipette (108, 110) positionable in at least one of the wells and a cap member (86) arranged to carry the pipette. The cap member can be releasably fastened to the base member. An extension member (28) defines at least one further well (40, 42, 44) and can be fastened to the base member such that the pipette is then positionable in at least one of the wells of the base and in the further well of the extension member.Type: ApplicationFiled: November 19, 2017Publication date: June 7, 2018Applicant: AXIS-SHIELD ASInventors: Lars Ørning, Frank Frantzen, Andrew Thomas Campbell, Arve Strømsheim
-
Patent number: 9857384Abstract: An assay cartridge has a base member (26) that defines at least two wells (30, 32, 34, 36, 38), a pipette (108, 110) positionable in at least one of the wells and a cap member (86) arranged to carry the pipette. The cap member can be releasably fastened to the base member. An extension member (28) defines at least one further well (40, 42, 44) and can be fastened to the base member such that the pipette is then positionable in at least one of the wells of the base and in the further well of the extension member.Type: GrantFiled: November 9, 2012Date of Patent: January 2, 2018Assignee: Axis-Shield ASInventors: Lars Ørning, Frank Frantzen, Andrew Thomas Campbell, Arve Strøsheim
-
Publication number: 20170349933Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: ApplicationFiled: June 21, 2017Publication date: December 7, 2017Applicant: AXIS-SHIELD ASInventors: Arne Ludvig FAAREN, Frank FRANTZEN, Arne Kristian NORDHEI, Erling SUNDREHAGEN, Lars ØRNING
-
Patent number: 9695464Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: GrantFiled: November 9, 2012Date of Patent: July 4, 2017Assignee: AXIS-SHIELD ASInventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
-
Patent number: 9140710Abstract: An assay method for determining transcobalamin saturation wherein a transcobalamin containing liquid sample is contacted with a porous substrate with immobilized thereon a transcobalamin immobilizing ligand and with a reporter-labelled transcobalamin binding partner and wherein signals from reporter labels which become immobilized on said substrate are detected, characterized in that one of said ligand or said binding partner comprises a first ligand or binding partner capable of specific binding to holo transcobalamin and a second ligand or binding partner capable of binding to apo transcobalamin or to holo and apo transcobalamin.Type: GrantFiled: October 24, 2008Date of Patent: September 22, 2015Assignee: AXIS-SHIELD ASAInventor: Lars Örning
-
Publication number: 20140302611Abstract: An assay cartridge has a base member (26) that defines at least two wells (30, 32, 34, 36, 38), a pipette (108, 110) positionable in at least one of the wells and a cap member (86) arranged to carry the pipette. The cap member can be releasably fastened to the base member. An extension member (28) defines at least one further well (40, 42, 44) and can be fastened to the base member such that the pipette is then positionable in at least one of the wells of the base and in the further well of the extension member.Type: ApplicationFiled: November 9, 2012Publication date: October 9, 2014Inventors: Lars Ørning, Frank Frantzen, Andrew Thomas Campbell, Arve Strømsheim
-
Publication number: 20140302540Abstract: The invention provides an enzymatic method for measuring the concentration of one or more analytes in the plasma portion of a blood derived sample, containing a first and a second component, where said second component interferes with the measurement of said first component.Type: ApplicationFiled: November 9, 2012Publication date: October 9, 2014Inventors: Arne Ludvig Faaren, Frank Frantzen, Arne Kristian Nordhei, Erling Sundrehagen, Lars Ørning
-
Publication number: 20120064533Abstract: A molecule which recognises holo-DBP but which does not recognise apo-DBP or has relatively low affinity thereto.Type: ApplicationFiled: March 2, 2010Publication date: March 15, 2012Inventors: Margaret Lawlor, David Pritchard, Murdo Black, Lars Ørning
-
Publication number: 20110020379Abstract: The present invention provides a specific binding partner for holoTC having a specificity for holoTC over apoTC of at least 40-fold and an assay method for assaying for holoTC in a sample, the method comprising contacting the sample with a specific binding partner for holoTC and detecting the resultant conjugates.Type: ApplicationFiled: November 3, 2009Publication date: January 27, 2011Applicant: AXIS-SHIELD ASAInventors: LARS ÖRNING, ANNE RIAN
-
Publication number: 20100099129Abstract: An assay method for determining transcobalamin saturation wherein a transcobalamin containing liquid sample is contacted with a porous substrate with immobilized thereon a transcobalamin immobilizing ligand and with a reporter-labelled transcobalamin binding partner and wherein signals from reporter labels which become immobilized on said substrate are detected, characterised in that one of said ligand or said binding partner comprises a first ligand or binding partner capable of specific binding to holo transcobalamin and a second ligand or binding partner capable of binding to apo transcobalamin or to holo and apo transcobalamin.Type: ApplicationFiled: October 24, 2008Publication date: April 22, 2010Applicant: AXIS - SHIELD ASAInventor: Lars ÖRNING
-
Patent number: 7632648Abstract: The present invention provides a specific binding partner for holoTC having a specificity for holoTC over apoTC of at least 40-fold and an assay method for assaying for holoTC in a sample, the method comprising contacting the sample with a specific binding partner for holoTC and detecting the resultant conjugates.Type: GrantFiled: November 26, 2003Date of Patent: December 15, 2009Assignee: Axis-Shield ASAInventors: Lars Örning, Anne Rian
-
Patent number: 7501287Abstract: An assay method for determining transcobalamin saturation wherein a transcobalamin containing liquid sample is contacted with a porous substrate with immobilized thereon a transcobalamin immobilizing ligand and with a reporter-labelled transcobalamin binding partner and wherein signals from reporter labels which become immobilized on said substrate are detected, characterised in that one of same ligand or said binding partner comprises a first ligand or binding partner capable of specific binding to holo transcobalamin and a second ligand or binding partner capable of binding to apo transcobalamin or to holo and apo transcobalamin.Type: GrantFiled: April 23, 2002Date of Patent: March 10, 2009Assignee: Axis-Shield ASAInventor: Lars Örning
-
Patent number: 7344849Abstract: The present invention relates to assay methods for the determination of cobalamin or vitamin B12 in a body fluid and in particular to assay methods for the metabolically active pool of cobalamin, comprising contacting a cell free sample of a body fluid with an immobilised or immobilizable specific binding ligand for TC II or holo TC II, separating a ligand bound fraction from a non-ligand bound fraction and measuring the holo-TC II or TC-II bound cobalamin content therein.Type: GrantFiled: July 23, 2004Date of Patent: March 18, 2008Assignee: Axis-Shield ASAInventors: Erling Sundrehagen, Lars Örning